Hui Zhang

Dr. Hui Zhang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
LHLingjuan He
Lingjuan He
YLYan Li
Yan Li
YLYi Li
Yi Li
WPWenjuan Pu
Wenjuan Pu
XHXiuzhen Huang
Xiuzhen Huang
BZBin Zhou
Bin Zhou

2 March 2018 in Circulation Research
Verified
Journal Article
Open access
PDF file
HZHui Zhang
Hui Zhang
KLKathy Lui
Kathy Lui
BZBin Zhou
Bin Zhou
Endocardial cells are specialized endothelial cells that form the innermost layer of the heart wall. By virtue of genetic lineage–tracing technology, many of the unexpected roles of endocardium during murine heart development, diseases, and regeneration have been identified recently. In addition to heart valves developed from the well-known endothelial to mesenchymal transition, recent fate-mapping studies using mouse models reveal that multiple cardiac cell lineages are also originated from the endocardium. This review focuses on a variety of different cell types that are recently reported to be endocardium derived during murine heart development, diseases, and regeneration. These multiple cell fates underpin the unprecedented roles of endocardial progenitors in function, pathological progression, and regeneration of the heart. Because emerging studies suggest that developmental mechanisms can be redeployed and recapitulated in promoting heart disease development and also cardiac repair and regeneration, understanding the mechanistic regulation of endocardial plasticity and modulation of their cell fate conversion may uncover new therapeutic potential in facilitating heart regeneration.

15 August 2017 in Cell Research
Verified
Journal Article
Open access
PDF file
HZHui Zhang
Hui Zhang
XHXiuzhen Huang
Xiuzhen Huang
KLKuo Liu
Kuo Liu
JTJuan Tang
Juan Tang
LHLingjuan He
Lingjuan He
BZBin Zhou
Bin Zhou
Endocardial fibroelastosis (EFE) refers to the thickening of the ventricular endocardium as a result of de novo deposition of subendocardial fibrous tissue layers during neonatal heart development. The origin of EFE fibroblasts is proposed to be postnatal endocardial cells that undergo an aberrant endothelial-to-mesenchymal transition (EndMT). Genetic lineage tracing of endocardial cells with the inducible endocardial Cre line Npr3-CreER and the endothelial cell tracing line Cdh5-CreER on an EFE-like model did not reveal any contribution of neonatal endocardial cells to fibroblasts in the EFE-like tissues. Instead, lineage tracing of embryonic epicardium by Wt1-CreER suggested that epicardium-derived mesenchymal cells (MCs) served as the major source of EFE fibroblasts. By labeling MCs using Sox9-CreER, we confirmed that MCs of the embryonic heart expand and contribute to the majority of neonatal EFE fibroblasts. During this pathological process, TGFβ signaling, the key mediator of fibroblasts activation, was highly upregulated in the EFE-like tissues. Targeting TGFβ signaling by administration of its antagonist bone morphogenetic protein 7 effectively reduced fibroblast accumulation and tissue fibrosis in the EFE-like model. Our study provides genetic evidence that excessive fibroblasts in the EFE-like tissues mainly originate from the epicardium-derived MCs through epicardial to mesenchymal transition (EpiMT). These EpiMT-derived fibroblasts within the EFE-like tissues could serve as a potential therapeutic target.

13 August 2024 in Cell Discovery
Verified
Journal Article
Open access
PDF file
ZGZibei Gao
Zibei Gao
LYLei Yan
Lei Yan
JMJufeng Meng
Jufeng Meng
ZLZhengkai Lu
Zhengkai Lu
KGKaixin Ge
Kaixin Ge
HZHui Zhang
Hui Zhang


23 October 2020 in Circulation Research
Verified
Journal Article
Closed access
PDF file
TFTeng Feng
Teng Feng
ZGZibei Gao
Zibei Gao
SKShan Kou
Shan Kou
XHXinyan Huang
Xinyan Huang
ZJZhen Jiang
Zhen Jiang
HZHui Zhang
Hui Zhang
Rationale: Endothelial cells are thought to emerge de novo from the mesoderm to form the entire circulatory system. Recently, erythro-myeloid progenitors (EMPs) have been proposed to be another remarkable developmental origin for blood vessels in multiple organs, including the hindbrain, liver, lung, and heart, as demonstrated by lineage tracing studies using different genetic tools. These observations challenge the current consensus that intraembryonic vessels are thought to expand solely by the proliferation of preexisting endothelial cells. Resolution of this controversy over the developmental origin of endothelial cells is crucial for developing future therapeutics for vessel-dependent organ repair and regeneration. Objective: To examine the contribution of EMPs to intraembryonic endothelial cells. Methods and Results: We first used a transgenic mouse expressing a tamoxifen-inducible Mer-iCre fusion protein driven by the Csf1r (colony stimulating factor 1 receptor) promoter. Genetic lineage tracing based on Csf1r-Mer-iCre-Mer showed no contribution of EMPs to brain endothelial cells identified by several markers. We also generated a knock-in mouse line by inserting an internal ribosome entry site-iCre cassette into the 3′ untranslated region of Csf1r gene to further investigate the cellular fates of EMPs. Similarly, we did not find any Csf1r-ires-iCre traced endothelial cells in brain, liver, lung, or heart in development either. Additionally, we found that Kit (KIT proto-oncogene receptor tyrosine kinase) was expressed not only in EMPs but also in embryonic hindbrain endothelial cells. Therefore, Kit promoter–driven recombinase, such as Kit-CreER, is a flawed tool for lineage tracing when examining the contribution of EMPs to hindbrain endothelial cells. We also traced CD45 (protein tyrosine phosphatase receptor type C; Ptprc) + circulating EMPs and did not find any CD45 lineage-derived endothelial cells during development. Conclusions: Our study suggested that EMPs are not the origin of intraembryonic endothelial cells.